26.12.2014 Views

Clinical Biochemistry of Domestic Animals (Sixth Edition) - UMK ...

Clinical Biochemistry of Domestic Animals (Sixth Edition) - UMK ...

Clinical Biochemistry of Domestic Animals (Sixth Edition) - UMK ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

356<br />

Chapter | 12 Diagnostic Enzymology <strong>of</strong> <strong>Domestic</strong> <strong>Animals</strong><br />

in liver than other organs led to the early conclusion that<br />

increases <strong>of</strong> ALT activity in serum are specific for hepatocellular<br />

injury, there is clear evidence that serum ALT<br />

activity can also be increased as a result <strong>of</strong> injury to myocytes<br />

as well. Dogs in a colony with canine X-linked muscular<br />

dystrophy and ongoing muscle necrosis had increased<br />

serum CK, AST, and up to a 25-fold increase in ALT activity<br />

but a normal SDH activity, suggesting that myonecrosis<br />

contributed to the increased serum ALT activity ( Valentine<br />

et al. , 1988 ). This is consistent with the presence <strong>of</strong> some<br />

ALT activity in cardiac and skeletal muscle <strong>of</strong> dogs. In a<br />

case report <strong>of</strong> a cat with myokymia and neuromyotonia,<br />

the CK activity was 28,380, whereas the ALT activity was<br />

only 195 U/l; in a study <strong>of</strong> rhabdomyolysis in three dystrophin-deficient<br />

cats, the CK activity ranged up to 2040<br />

times the upper limit <strong>of</strong> the reference range, whereas the<br />

ALT activity only increased to 19 times the upper limit <strong>of</strong><br />

the reference range, suggesting only a minimal increase <strong>of</strong><br />

serum ALT activity should be expected with muscle injury<br />

in this species ( Galano et al. , 2005 ; Gaschen et al. , 1998 ).<br />

Although at least one early study in dogs showed a<br />

correlation between the magnitude <strong>of</strong> serum ALT activity<br />

and histological evidence <strong>of</strong> necrosis, other studies<br />

have reported little correlation (VanVleet and Albert,<br />

1968 ) . Similarly, bile duct ligation <strong>of</strong> dogs led to a 25-fold<br />

increase in serum ALT activity with minimal evidence <strong>of</strong><br />

hepatocellular necrosis. As discussed in the introduction,<br />

the recognition <strong>of</strong> the formation <strong>of</strong> membrane blebs on<br />

hepatocytes and the rupture <strong>of</strong> these blebs during various<br />

conditions such as endotoxic shock, carbon tetrachlorideinduced<br />

injury, cholestasis, and experimentally induced<br />

hypoxia have led to the understanding that there can be<br />

an increase <strong>of</strong> serum enzymes derived from the cytoplasm<br />

<strong>of</strong> the cell in cases <strong>of</strong> reversible cellular injury. In summary,<br />

the observation <strong>of</strong> increased serum ALT activity<br />

indicates hepatocellular (or myocyte) injury, but it does not<br />

necessarily imply irreversible injury and does not suggest a<br />

specific cause.<br />

B . Aspartate Aminotransferase<br />

Aspartate aminotransferase (AST: EC 2.6.1.1) (formerly<br />

glutamic oxaloacetic transaminase; GOT) catalyzes the<br />

transamination <strong>of</strong> L-aspartate and 2-oxoglutatarate to oxaloacetate<br />

and glutamate. As with ALT, pyridoxal-5 -phosphate<br />

(PP) is required as a c<strong>of</strong>actor. Although serum ALT was<br />

poorly saturated with PP in a study following exercise in<br />

horses, 94% <strong>of</strong> the AST was saturated and present as the<br />

holoenzyme ( Rej et al. , 1990 ). Providing PP in the assay<br />

reagent may be less <strong>of</strong> a concern when determining serum<br />

AST activity than when determining serum ALT activity.<br />

AST activity is relatively high and in similar amounts<br />

in liver and in skeletal and cardiac muscle, but it varies<br />

between species ( Boyd, 1983 ; Keller, 1981 ). It is routinely<br />

used in equine and food animal medicine as a screening<br />

test for injury to both organs. Serum AST activity is readily<br />

available on the biochemical pr<strong>of</strong>ile, has a longer blood<br />

half-life than sorbitol dehydrogenase and creatine kinase,<br />

and is stable for days in serum at room temperature, refrigerated,<br />

or frozen. AST is found in erythrocytes, and the<br />

addition <strong>of</strong> erythrocyte lysate to serum increases the apparent<br />

AST activity (unpublished data).<br />

AST is located in the cytosol but is in higher concentrations<br />

in mitochondria. There is only 48.1% amino acid<br />

sequence homology between cytosolic AST (cAST) and<br />

mitochondrial AST (mAST) from horse heart ( Doonan<br />

et al. , 1986 ). Likewise, the nucleotide sequences <strong>of</strong> cDNA<br />

<strong>of</strong> bovine mAST and cAST are also distinctly different<br />

( Aurila et al. , 1993 ; Palmisano et al. , 1995 ). Although<br />

there have been some efforts to show enhanced ability to<br />

identify organ-specific injury by assays for mAST and<br />

cAST, this has been shown to be <strong>of</strong> no diagnostic value<br />

( Jones and Blackmore, 1982 ). It may be theoretically<br />

possible to estimate the magnitude <strong>of</strong> reversible versus<br />

irreversible cell injury by determining mAST and cAST<br />

separately; however, this has not been studied empirically.<br />

Although the half-life <strong>of</strong> AST has been reported to be<br />

as long as 7 to 8 days in horses and as short as 163min<br />

in dogs, neither <strong>of</strong> these seems reasonable based on data<br />

obtained following carbon tetrachloride toxicity ( Fleisher<br />

and Wakim, 1963 ; Zinkl et al. , 1971 ). Decreasing serum<br />

AST activity in horses recovering from CCl 4 -induced hepatotoxicity,<br />

as well as studies <strong>of</strong> equine myoglobinuria,<br />

suggests a half-life <strong>of</strong> 3 to 4 days ( Bernard and Divers,<br />

1989 ; Cardinet et al. , 1967 ; Noonan, 1981 ). In cattle with<br />

mild CCl 4 -induced hepatotoxicity, serum AST activity during<br />

recovery suggests a half-life <strong>of</strong> approximately 1 day<br />

( Yonezawa et al. , 2005 ). Serum AST has a longer half-life<br />

than creatine kinase, and therefore it would be expected to<br />

have increased diagnostic sensitivity during recovery from<br />

myocyte or hepatocyte injury.<br />

Increased serum AST activity is observed with both<br />

reversible and irreversible injury to hepatocytes and can be<br />

seen following hepatocellular injury and cholestasis, similar<br />

to serum ALT activity in dogs and cats. Likewise, serum<br />

AST is increased following myocyte injury. In either case,<br />

the definitive disease process cannot be identified, only<br />

that cellular injury in muscle or liver has occurred. Because<br />

serum AST activity cannot differentiate between hepatocellular<br />

or myocyte injury, further testing is <strong>of</strong>ten required<br />

using organ-specific enzymes such as sorbitol dehydrogenase<br />

or creatine kinase. Markedly increased serum AST and<br />

sorbitol dehydrogenase activity suggest acute or active<br />

hepatocellular injury, and markedly increased serum AST<br />

with modest to moderate sorbitol dehydrogenase activity<br />

suggests chronic hepatic injury or recovery from acute<br />

liver injury. Similar conclusions can be drawn using serum<br />

AST and creatine kinase activity. As with other cytosolic<br />

enzymes, serum AST activity cannot distinguish between

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!